Company Filing History:
Years Active: 2015
Title: Innovations of Gary James Miller in Pharmaceutical Cocrystals
Introduction: Gary James Miller is an accomplished inventor based in Glasgow, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cocrystals. With a focus on enhancing pharmaceutical development, Gary has made strides in the realm of solid forms of agomelatine.
Latest Patents: Gary holds a patent for "Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation." This invention relates to novel solid forms of agomelatine, specifically highlighting three pharmaceutically acceptable cocrystals that possess physico-chemical properties suitable for pharmaceutical advancement. The methods developed for their preparation further add to the significance of this patent in the pharmaceutical industry.
Career Highlights: Gary is currently associated with Zentiva K.s., a company known for its commitment to pharmaceutical innovation and development. His work has not only added to his credentials but has also contributed to the overall advancement of pharmaceutical formulations that can be beneficial in improving patient outcomes.
Collaborations: Throughout his career, Gary has collaborated with notable professionals in the field, including Ludek Ridvan and Jindrich Richter. These collaborations underscore his commitment to research and development, as well as his ability to work with other experts to achieve shared goals in the innovation of pharmaceutical products.
Conclusion: Gary James Miller's contributions to the field of pharmaceuticals through his patent on cocrystals demonstrate the importance of innovation in drug development. His collaboration with industry professionals and his position at Zentiva K.s. highlight his role as a key figure in the development of new pharmaceutical forms, reflecting the continuous evolution of science and technology in the healthcare sector.